Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ECCO Guidelines on Inflammatory Bowel Disease and Malignancies.
Gordon H, Biancone L, Fiorino G, Katsanos KH, Kopylov U, Al Sulais E, Axelrad JE, Balendran K, Burisch J, de Ridder L, Derikx L, Ellul P, Greuter T, Iacucci M, Di Jiang C, Kapizioni C, Karmiris K, Kirchgesner J, Laharie D, Lobatón T, Molnár T, Noor NM, Rao R, Saibeni S, Scharl M, Vavricka SR, Raine T. Gordon H, et al. Among authors: karmiris k. J Crohns Colitis. 2023 Jun 16;17(6):827-854. doi: 10.1093/ecco-jcc/jjac187. J Crohns Colitis. 2023. PMID: 36528797 Free article. No abstract available.
Pharmacogenetic analysis of canonical versus noncanonical pathway of NF-kB in Crohn's disease patients under anti-tumor necrosis factor-α treatment.
Stavrou EF, Chatzopoulou F, Antonatos C, Pappa P, Makridou E, Oikonomou K, Kapsoritakis A, Potamianos PS, Karmiris K, Tzathas C, Chatzidimitriou D, Vizirianakis IS, Vasilopoulos Y. Stavrou EF, et al. Among authors: karmiris k. Pharmacogenet Genomics. 2022 Aug 1;32(6):235-241. doi: 10.1097/FPC.0000000000000471. Epub 2022 Jun 22. Pharmacogenet Genomics. 2022. PMID: 35852914
Rectal perforation caused by colonoscopic retroflexion.
Tribonias G, Konstantinidis K, Theodoropoulou A, Vardas E, Karmiris K, Velegrakis M, Paspatis GA. Tribonias G, et al. Among authors: karmiris k. Gastrointest Endosc. 2010 Mar;71(3):662. doi: 10.1016/j.gie.2009.05.033. Gastrointest Endosc. 2010. PMID: 20189536 No abstract available.
Pharmacokinetics of adalimumab in Crohn's disease.
Ternant D, Karmiris K, Vermeire S, Desvignes C, Azzopardi N, Bejan-Angoulvant T, van Assche G, Paintaud G. Ternant D, et al. Among authors: karmiris k. Eur J Clin Pharmacol. 2015 Sep;71(9):1155-7. doi: 10.1007/s00228-015-1892-1. Epub 2015 Jun 27. Eur J Clin Pharmacol. 2015. PMID: 26115613 Free article. No abstract available.
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects.
Allez M, Karmiris K, Louis E, Van Assche G, Ben-Horin S, Klein A, Van der Woude J, Baert F, Eliakim R, Katsanos K, Brynskov J, Steinwurz F, Danese S, Vermeire S, Teillaud JL, Lémann M, Chowers Y. Allez M, et al. Among authors: karmiris k. J Crohns Colitis. 2010 Oct;4(4):355-66. doi: 10.1016/j.crohns.2010.04.004. Epub 2010 Jun 29. J Crohns Colitis. 2010. PMID: 21122530 Free article.
92 results